Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adaptive Immunity
9%
All-neural
9%
Anti-neuroinflammation
100%
Antiviral Drugs
9%
Astrocytes
100%
Astroglia
9%
Blood-brain Barrier
9%
Brain Function
9%
Comorbidity
9%
Cytokine Signaling
9%
Direct Toxicity
9%
Disease Progression
9%
Dopamine
9%
Drug Regimen
9%
Dysregulated
9%
Gene Expression
9%
Gene Function
9%
Glial Activation
9%
HIV-associated Neurocognitive Disorders
27%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Human Immunodeficiency virus-1 Infection
9%
Indirect Mechanism
9%
Infiltration
9%
Innate Immunity
9%
Intervention Targets
9%
Intracellular Signaling
9%
Lymphocyte Activity
9%
Lymphocyte Count
9%
Methamphetamine
100%
Methamphetamine Abuse
18%
Methamphetamine Use
18%
Neurocognitive Disorders
9%
Neuroimmune Response
9%
Neuroinflammation
36%
Neuronal Activity
18%
Neuronal Cells
9%
Neuronal Signaling
9%
Neurotoxicity
9%
Novel Therapeutics
9%
Oxidative Stress
9%
Patient Report
9%
Phagocytic Activity
9%
Popular
9%
Psychostimulants
9%
Reactive Gliosis
9%
Reward Pathway
9%
Signaling Genes
9%
Viral Infection
9%
Medicine and Dentistry
Adaptive Immunity
14%
Astrocyte
100%
Blood Brain Barrier
14%
Brain Function
14%
Comorbidity
14%
Cytokine Signaling
14%
Disease Exacerbation
14%
Disorders of Higher Cerebral Function
57%
Excitotoxicity
14%
Gene Expression
14%
Gene Function
14%
Gliosis
14%
Human Immunodeficiency Virus
42%
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus 1 Infection
14%
Innate Immunity
14%
Intracellular Signaling
14%
Lymphocyte
14%
Methamphetamine
100%
Nervous System Cell
14%
Neuroinflammation
57%
Oxidative Stress
14%
Population
14%
Psychostimulant
14%
Signal Transduction
14%
Virus Infection
14%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
14%
Comorbidity
14%
Cytokine
14%
Disease Exacerbation
14%
Disorders of Higher Cerebral Function
57%
Excitotoxicity
14%
Gliosis
14%
HIV
42%
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus 1 Infection
14%
Methamphetamine
100%
Nervous System Inflammation
57%
Psychostimulant
14%
Virus Infection
14%
Neuroscience
Adaptive Immunity
9%
Antiretroviral Drugs
9%
Astrocyte
100%
Blood Brain Barrier
9%
Brain Function
9%
Cell Signaling
9%
Comorbidity
9%
Excitotoxicity
9%
Gene Expression
9%
Gene Function
9%
Gliosis
9%
Human Immunodeficiency Virus
100%
Intracellular Signaling
9%
Lymphocyte
9%
Nervous System Cell
9%
Neuronal Activity
9%
Oxidative Stress
9%
Psychostimulant
9%
Immunology and Microbiology
Adaptive Immune System
9%
Astrocyte
100%
Blood Brain Barrier
9%
Brain Function
9%
Comorbidity
9%
Cytokine Signaling
9%
Gene Expression
9%
Gene Function
9%
Human Immunodeficiency Virus 1
100%
Innate Immune System
9%
Intracellular Signaling
9%
Lymphocyte
9%
Oxidative Stress
9%
Population
9%
Signal Transduction
9%
Viral Disease
9%